Covalent design

Version Compatibility

Reference examples tested with: RDKit 2024.09+, OpenEye / AutoDock Vina 1.2+ (for covalent extensions), GOLD (commercial), DOCKovalent (web service), HCovDock 1.0+.

Before using code patterns, verify installed versions match. If versions differ:

• Python: pip show rdkit then help(rdkit.Chem) to check signatures
• CLI: check version output of each docking tool

If code throws ImportError, AttributeError, or TypeError, introspect the installed package and adapt the example to match the actual API rather than retrying.

Covalent Inhibitor Design

Design molecules that form covalent bonds with target protein residues. Clinically validated targeted covalent inhibitors include KRAS G12C inhibitors (sotorasib, adagrasib), BTK inhibitors (ibrutinib), and EGFR inhibitors (osimertinib). Covalent design requires balancing intrinsic reactivity (must form bond) vs selectivity (only the intended residue), reversibility (irreversible vs reversible covalent), and drug-likeness (warheads can hurt PK).

For warhead substructure filtering (in non-covalent contexts), see chemoinformatics/substructure-search. For non-covalent docking, see chemoinformatics/virtual-screening. For pose validation, see chemoinformatics/pose-validation.

Reactive Residue Taxonomy

Residue	Nucleophile	Example compatible warheads	Design note
Cysteine	Thiol / thiolate	Acrylamide, haloacetamide, nitrile	Commonly targeted; local pKa and geometry control reactivity
Lysine	Amine	Sulfonyl fluoride, aldehyde	Aldehydes can form reversible imines with amines
Serine	Alcohol / alkoxide	β-lactam, boronate	Often requires catalytic activation
Threonine	Alcohol / alkoxide	Boronate	Context-dependent and less commonly targeted
Tyrosine	Phenol / phenolate	Sulfonyl fluoride, fluorosulfate	Local environment strongly affects reaction
Aspartate/Glutamate	Carboxylate	Residue-specific electrophiles require experimental validation	Do not infer aldehyde Schiff-base formation with carboxylates

Cysteine is frequently targeted because its thiol/thiolate can be nucleophilic and its local environment can support selective proximity-driven reaction. GSH and off-target cysteines are competing thiols, not intrinsically distinguishable from the target by the warhead alone; the complete ligand's recognition, exposure, and intrinsic reactivity determine selectivity.

Warhead Chemistry

Warhead	SMARTS pattern	Reactivity	Reversibility	Cys-selective
Acrylamide	[CX3](=[OX1])([NX3])[CX3]=[CX3]	Moderate (Michael acceptor)	Usually irreversible	Often Cys-directed
Chloroacetamide	[CX3](=[OX1])([NX3])[CH2]Cl	High (SN2)	Irreversible	Often Cys-directed
α-haloketone	[CX3](=O)C[F,Cl,Br]	Very high	Irreversible	Yes (but reactive)
Vinyl sulfone	S(=O)(=O)C=C	Moderate (Michael)	Irreversible	Yes
Sulfonyl fluoride	S(=O)(=O)F	Moderate	Irreversible	Lys/Tyr/Ser
Fluorosulfate (SuFEx)	OS(=O)(=O)F	Moderate	Irreversible	Tyr/Lys
Aldehyde	[CX3H1](=O)	Variable	Often reversible (covalent equilibrium)	Context-dependent Cys/Lys/Ser chemistry
Boronate (B-OH or B(OH)2)	B(O)O	Moderate	Reversible	Ser/Thr
Nitrile	C#N	Low	Reversible (Cys-S adduct)	Cys
Epoxide	C1OC1	High	Irreversible	Cys/Lys/Asp
α,β-unsaturated ketone	[CX3](=O)C=C	Moderate (Michael)	Irreversible	Cys
Isothiocyanate	N=C=S	High	Irreversible	Cys/Lys
Maleimide	O=C1N(C(=O)C=C1)	Often high	Commonly irreversible under assay conditions	Often Cys-directed
Cysteine-selective heterocycle	various	Moderate	Variable	Yes (designed)

Practical hierarchy: Acrylamides are common attenuated electrophiles in cysteine-directed TCIs, including KRAS G12C, EGFR, and BTK programs. Haloacetamides are generally more intrinsically reactive, but actual selectivity must be measured for the complete molecule and target context.

Decision Tree by Scenario

Goal	Warhead choice	Reactivity tier
Cysteine TCI program	Acrylamide is one common starting class	Measure complete-compound target and intrinsic reactivity
Cysteine probe program	Haloacetamides are one common class	Higher intrinsic reactivity can aid labeling but requires selectivity profiling
Lysine TCI (uncommon)	Sulfonyl fluoride	Moderate
Tyrosine TCI	Fluorosulfate (SuFEx)	Moderate
Reversible covalent	Warhead with demonstrated reversible adduct chemistry, such as selected cyanoacrylamides, aldehydes, nitriles, or boronates	Confirm reversibility experimentally
Activity-based protein profiling (ABPP)	Iodoacetamide / chloroacetamide	Very high
Boronic acid inhibitor (proteasome)	Boronate	Reversible
Aldehyde inhibitor (calpain)	Aldehyde	Reversible covalent

Kinetics: kinact / Ki

Covalent inhibition kinetics:

• Ki: reversible binding affinity (initial, like non-covalent IC50)
• kinact: rate of covalent bond formation (sec^-1)
• kinact/Ki: second-order rate constant, "covalent efficiency" (M^-1 s^-1)

For irreversible two-step inhibition that follows the corresponding kinetic model, report fitted kinact, Ki, and kinact/Ki rather than only a time-dependent IC50. Two compounds with the same IC50 can have different kinetic components:

• Low Ki, low kinact: tight binding, slow covalent bond
• High Ki, high kinact: loose binding, fast covalent bond

Because kinact/Ki depends on the target, construct, assay conditions, and kinetic model, compare values within a matched assay series and alongside exposure, intrinsic reactivity, target engagement, and selectivity. Reversible-covalent systems may require different mechanistic models and residence-time or washout measurements.

Intrinsic Reactivity Assays

Before committing to a warhead, measure intrinsic reactivity (off-target risk):

# Generic GSH stability assay readout - measure half-life of warhead with 10 mM GSH
# kinact_GSH from time-course of warhead disappearance

Do not assign a universal GSH half-life from the warhead name alone. Substitution, electronics, ionization, solubility, and assay conditions can change the observed rate. Report the GSH concentration, buffer, temperature, analytical method, and fitted half-life or second-order rate constant for the complete compound.

Covalent Docking Tools

Tool	Approach	Strength	Fails when
DOCKovalent (London et al 2014 Nat Chem Biol 10:1066)	Constraint-based DOCK	Free, well-validated	Browser-based; small library
GOLD covalent (CCDC)	GOLD with covalent constraint	Commercial; selectivity	License cost
AutoDock 4 covalent	AD4 with covalent bond	Open source	Slower than Vina
CovDock (Schrödinger)	Glide-based + covalent	Commercial two-stage covalent docking workflow	License cost
MOE covalent	Triposite Discovery	Commercial	License cost
HCovDock (Wu Q, Huang S-Y 2023 Briefings Bioinform 24:bbac559)	Hierarchical fragment + covalent	Open; supports many residues	Newer, less validated
ICM-Pro covalent	Active site grid + covalent	Commercial; metal centers	License cost

For open-source covalent docking, HCovDock (2023) is the modern alternative; DOCKovalent is the longstanding standard.

Example: KRAS G12C Inhibitor Design Workflow

Goal: Decorate a co-crystal scaffold with a cysteine-targeting warhead and rank candidates by covalent efficiency.

Approach: Load scaffold SMILES, enumerate acrylamide-bearing analogs, filter by reactivity selectivity, dock under covalent constraint, and rank by kinact/Ki surrogates.

from rdkit import Chem

# Step 1: scaffold from co-crystal (4LRW or AMG510)
scaffold_smi = 'c1ccc(C(=O)NCC)cc1'  # generic valid scaffold for code illustration
scaffold = Chem.MolFromSmiles(scaffold_smi)

# Step 2: enumerate analogs with acrylamide warhead
def add_acrylamide(scaffold, attachment_atom_idx):
    """Project hook: attach a mapped acrylamide with an audited reaction."""
    raise NotImplementedError(
        'Provide a project-specific mapped reaction and validate atom mapping, '
        'valence, regioisomer identity, and product sanitization.'
    )

# Step 3: filter for reactive group selectivity
# Step 4: dock with DOCKovalent / GOLD covalent / HCovDock
# Step 5: rank by kinact/Ki surrogate (compute reactive Michael acceptor reactivity)

Reactivity Surrogates (computed without experiment)

For ranking warheads without wet-lab data:

Descriptor	Use case
LUMO energy (DFT)	Michael acceptor reactivity (lower LUMO = more reactive)
Electrophile partial charge	SN2 reactivity
RDKit rdMolDescriptors.CalcLabuteASA	Steric accessibility
Experimentally supported binding pose or validated docking model	Geometric fit to reactive residue

Goal: Record alpha-carbon substitution as a structural feature for an acrylamide series.

Approach: Parse the SMILES, locate the acrylamide substructure, and count neighbors on the alpha carbon outside the matched warhead. This count is not a LUMO estimate or a stand-alone reactivity prediction; substituent electronics and the rest of the molecule must be considered, and reactivity should be measured.

def acrylamide_alpha_substitution_count(smi):
    mol = Chem.MolFromSmiles(smi)
    if mol is None:
        return None
    acryl_pat = Chem.MolFromSmarts(
        '[CX3:1](=[OX1:2])([NX3:3])[CX3:4]=[CX3:5]'
    )
    matches = mol.GetSubstructMatches(acryl_pat, uniquify=True)
    if not matches:
        return None
    alpha_query_idx = next(
        atom.GetIdx() for atom in acryl_pat.GetAtoms()
        if atom.GetAtomMapNum() == 4
    )
    alpha_c = mol.GetAtomWithIdx(matches[0][alpha_query_idx])
    n_subs = len([n for n in alpha_c.GetNeighbors() if n.GetIdx() not in matches[0]])
    return n_subs

For a reactivity model, use experimentally measured rates or a validated quantum-chemical workflow; a single frontier-orbital energy is not sufficient on its own.

Per-Tool Failure Modes

Wrong warhead for residue

Trigger: A warhead/residue pairing is assumed from a broad class label.

Mechanism: Reaction depends on the residue microenvironment, electrophile, binding pose, and catalytic assistance; a class label does not establish residue selectivity.

Symptom: No covalent adduct observed despite docking pose.

Fix: Use literature-supported residue/warhead chemistry as a hypothesis, then verify site-specific adduct formation and competing reactivity experimentally.

Excessive reactivity (off-target)

Trigger: Chloroacetamide in drug-candidate context.

Mechanism: Excess intrinsic electrophile reactivity can increase reaction with GSH and off-target nucleophiles.

Symptom: Toxicity in cell-based assays; non-specific binding signal.

Fix: Test a less intrinsically reactive electrophile and measure its GSH and target-reaction kinetics; alpha substitution can tune behavior but does not guarantee selectivity or stability.

Geometric mismatch

Trigger: The ligand's reactive atom is poorly positioned relative to the target nucleophile.

Mechanism: Covalent reaction requires warhead-specific distance and approach geometry between the electrophilic atom and the nucleophilic atom (Cys Sγ for cysteine).

Symptom: No covalent labeling in mass spec despite predicted docking.

Fix: Identify the reaction atoms, inspect the pre-reaction Sγ-to-electrophile distance and reaction-specific angles, and use a docking protocol parameterized for that reaction. Do not substitute Cβ distance for the reacting sulfur.

Reversibility unintended

Trigger: Designed irreversible TCI but warhead is reversible.

Mechanism: Reversibility depends on the complete electrophile, adduct chemistry, protein environment, and assay timescale; class-level labels are only hypotheses.

Symptom: Activity wanes after substrate washout in cellular assays.

Fix: Select chemistry with demonstrated behavior in the intended context and verify reversibility by dilution, washout, intact-protein MS, or another suitable experiment.

kinact/Ki conflation

Trigger: Optimizing for IC50 instead of kinact/Ki.

Mechanism: Compounds with same IC50 differ in covalent efficiency.

Symptom: Compounds with similar endpoint IC50 values show different time-dependent target engagement or pharmacodynamic duration.

Fix: Fit a mechanistically appropriate kinetic model. Use kinact/Ki for qualifying irreversible two-step systems; use equilibrium, residence-time, or washout measurements where appropriate for reversible covalent systems.

DOCKovalent over-prediction

Trigger: Default DOCKovalent run.

Mechanism: Covalent constraint forces docking; many ligands "succeed" but are unrealistic.

Symptom: Many compounds pass docking; few label in vitro.

Fix: Review measured/validated reactivity, reaction-atom geometry (Cys Sγ for cysteine), non-covalent recognition, strain, and site-specific experimental labeling.

Reconciliation: Irreversible vs Reversible Covalent

Aspect	Irreversible	Reversible covalent
Examples	KRAS G12C (acrylamide), BTK (ibrutinib)	Boronate (bortezomib), aldehyde (calpain inhibitors)
Toxicity profile	Off-target Cys labeling potential	Off-target equilibrium
Resistance mechanism	Mutation of reactive Cys	Mutation reduces affinity
Design decision	Consider duration of target engagement, safety, exposure, and resistance	Consider equilibrium, residence time, and recovery after washout

Common Errors

Symptom	Cause	Fix
Warhead not matching SMARTS	Different stereochemistry or charged	Use canonicalized + neutral SMARTS
DOCKovalent rejects ligand	No suitable Cys in pocket	Re-check residue accessibility
GSH adduct dominates	Warhead too reactive	Use less reactive warhead; or alpha-substitute
Off-target labeling in cells	Promiscuous warhead	Iterate warhead reactivity vs selectivity
Docking pose but no labeling	Geometric mismatch	Distance check; rotamer search
Intended irreversible inhibitor shows recovery after washout	Adduct chemistry is reversible or covalent reaction is incomplete	Re-evaluate the mechanism and fit the appropriate kinetic model
HCovDock fails on PROTAC	Tool optimized for monomer covalent	Use specialized tools for bivalent

References

• Lonsdale & Ward, Chem. Soc. Rev. 47:3816-3830 (2018) -- irreversible-inhibitor discovery, optimization, and kinetics (DOI 10.1039/C7CS00720C).
• Singh J, Petter RC, Baillie TA, Whitty A. Nat. Rev. Drug Discov. 10:307-317 (2011) -- TCI design principles (DOI 10.1038/nrd3410).
• London N et al., Nat. Chem. Biol. 10:1066-1072 (2014) -- DOCKovalent (DOI 10.1038/nchembio.1666).
• Wu Q et al., Brief. Bioinform. 24:bbac559 (2023) -- HCovDock (DOI 10.1093/bib/bbac559).
• Yu W, Weber DJ, MacKerell AD Jr. J. Chem. Theory Comput. 19:3007-3021 (2023) -- SILCS-Covalent and Cys-sulfur/reactive-atom geometry (DOI 10.1021/acs.jctc.3c00232).
• Backus et al., Nature 534:570-574 (2016) -- proteome-wide covalent ligand discovery (DOI 10.1038/nature18002).
• Pettinger et al., Angew. Chem. Int. Ed. 56:15200-15209 (2017) -- lysine-targeting covalent inhibitors (DOI 10.1002/anie.201707630).
• Ostrem et al., Nature 503:548-551 (2013) -- KRAS G12C disulfide-tethered fragments (DOI 10.1038/nature12796).

Related Skills

• chemoinformatics/molecular-io - Parse warhead SMILES
• chemoinformatics/substructure-search - Warhead SMARTS detection
• chemoinformatics/virtual-screening - Pre-dock candidate non-covalent fit
• chemoinformatics/pose-validation - Validate covalent docking
• chemoinformatics/conformer-generation - Warhead conformer ensembles
• chemoinformatics/admet-prediction - ADMET of covalent leads
• chemoinformatics/molecular-descriptors - Reactivity surrogate descriptors